Related Experiment Video

Updated: Jul 2, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

The positive and negative control actions of PTPase on IL-2 signaling

J Zhu1, H Ji, L Lu

  • 1Shanghai Institute of Biochemistry, Chinese Academy of Sciences, China.

Science in China. Series C, Life Sciences
|August 30, 2008
PubMed

Insights

Protein tyrosine phosphatase (PTPase) regulates the JAK-STAT pathway. While inhibiting PTPase can block IL-2 induced gene transcription and cause cell death, it also activates STAT5 signaling.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Immunology

Background:

  • Interleukin-2 (IL-2) signaling involves the JAK-STAT pathway.
  • Protein tyrosine phosphatases (PTPases) regulate intracellular signaling cascades.
  • STAT5 activation is crucial for IL-2 mediated cellular responses.

Purpose of the Study:

  • To investigate the role of PTPase in IL-2 induced JAK-STAT signaling.
  • To determine how PTPase activity affects STAT5 phosphorylation and activation.
  • To elucidate the dual role of PTPase in regulating gene expression and cell fate.

Main Methods:

  • Cell treatment with sodium n-vanadate (PTPase inhibitor).
  • Electrophoretic mobility shift assay (EMSA) to detect STAT5 activation.
  • Analysis of reporter gene expression.
  • Assessment of gene transcription (tnf-beta, c-myc) and cell viability.

Main Results:

  • Sodium n-vanadate increased intracellular protein tyrosine phosphorylation and STAT5 activation.
  • STAT5 activation by sodium n-vanadate was not fully inhibited by protein tyrosine kinase (PTK) inhibitors.
  • Sodium n-vanadate augmented IL-2 induced reporter gene expression.
  • PTPase inhibition blocked IL-2 induced tnf-beta and c-myc transcription, leading to cell death.

Conclusions:

  • PTPase negatively regulates the IL-2 induced JAK-STAT pathway.
  • PTPase inhibition can lead to STAT5 activation but blocks other IL-2 mediated gene transcription, resulting in cell death.
  • PTPase exhibits both positive and negative regulatory roles in IL-2 signaling pathways through its phosphatase activity.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...